Celéri Health in the News
From landmark data partnerships to regulatory-grade evidence infrastructure — follow Celéri's growing footprint in interventional pain and neuromodulation.
Conshohocken, PA — January 2025. Celéri Health and a national biologics company have entered into a real-world evidence partnership to generate structured, longitudinal outcomes data for the partner's regenerative tissue and biologic therapies used in interventional pain and spine care. Under the agreement, Celéri will deploy its EaaS™ (Evidence-as-a-Service) platform to collect condition-specific patient-reported outcomes directly from patients, establishing a Commercial Insights Registry™ for the partner's portfolio. The engagement is structured to scale toward a Regulatory-Grade Evidence Cohort™ — positioning the partner to build toward FDA-submissible real-world evidence as the dataset matures. The collaboration expands Celéri's real-world data capabilities beyond neuromodulation into the growing regenerative medicine space.
Celéri Health has released its AI-applied large language model (LLM), PatientFinder™, for use in patient matching for clinical trials and for point-of-care advanced therapy patient eligibility identification.
Read Release →Celéri Health and Guam Regional Medical City announce a first-of-its-kind pain safety net program bringing outcomes monitoring and access infrastructure to underserved SCS patients in the Pacific.
Read Release →Celéri Health's Research Group announces collaboration with Averitas Pharma on a post-market observational multi-center study examining outcomes in neuropathy patients.
Read Release →Celéri Health's technology innovation team, Celéri Labs, announces collaboration with Google to leverage Firebase and Google Cloud Platform services including BigQuery and Cloud AI for pain data machine learning and natural language processing.
Read Release →Celéri Health announces collaboration with CornerLoc™ on the pending multi-center SPARTAN Study, deploying Celéri's platform for patient outcomes data gathering and management.
Read Release →MedTech Strategist Digital Issue — Celéri brings real-world data and an AI-enabled platform to clinicians and therapy developers, building the biomarker infrastructure chronic pain has lacked.
Read Coverage →Celéri Health launches the PainRWD™ Science Cloud — a longitudinal, de-identified patient database enabling pain researchers and stakeholders to collaborate on real-world evidence at scale.
Read Release →Celéri partners with the UW–Madison Center for Health Disparities Research to integrate the Neighborhood Atlas® Area Deprivation Index (ADI) into clinical outcomes workflows.
Read Release →Interaxon, alongside Celéri Health and pain expert Dr. Ronald D. Siegel, announces clinical validation work for the Muse® mEEG Biofeedback system and new Transforming Pain eCourse.
Read Coverage →We want to talk to the right people.
For press inquiries, interview requests, or to discuss research collaborations and data partnerships — reach out directly. We respond within one business day.
Interested in becoming a Celéri partner?
Sponsors, research institutions, and health systems — let's build evidence together.
